NL-OMON32380尚未招募4 期
Mechanisms of Albuminuria in Diabetes: Reversal of Injury to the Glycocalyx by the Ace-inhibitor Lisinopril - MADRIGA
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Diagnosis of type 1 diabetes according to ADA criteria
- •Urinary albumin/creatinin ratio <3,5 mg/mmol, without antiproteinuric treatment
排除标准
- •Hypertension as defined by systolic blood pressure > 140 mmHg, diastolic blood pressure > 90 mmHg or use of antihypertensive drugs
- •Previous use of RAS inhibitors
- •Primary dyslipidemia*s
- •Use of statins during the six weeks before visit 1
- •Use of antioxidants in the two weeks prior to visit 1
- •Angioedema in medical history
- •Hypersensitivity to Ace inhibitors
研究者
相似试验
进行中（未招募）
不适用
Mechanisms of albuminuria in diabetes; reversal of injury to the glycocalyx by the ACE inhibitor lisinopril - MADRIGADiabetes mellitusEUCTR2008-002610-21-NLAcademic Medical Centre
尚未招募
不适用
Mechanisms of albuminuria in diabetes: reversal of injury to the glycocalyx by the ace-inhibitor lisinoprilDiabetes Mellitus, microalbuminuria, glycocalyx, ACE-inhibitorNL-OMON23821Academic Medical Center (AMC), Department of Internal Medicine20
尚未招募
不适用
Diabetes type 2 and the role of macroalbuminuria; a diagnostic tool for vascular ageing with 18F-NaF PET/CT imaging.NL-OMON22887niversity Medical Center Groningen50
已完成
不适用
DiabetEs Type 2 and thE Role of MacroalbumInuria; a diagnostic tool for vascular ageing with 18F-NaF PET/CT imagingatherosclerosevascular stiffness100126531002914910003216NL-OMON50619niversitair Medisch Centrum Groningen50
未知
2 期
Reducing Residual Albuminuria in Subjects with Diabetes and Nephropathy with AtrasentaJPRN-jRCT2080221551Abbott Japan Co., Ltd.54